Cargando…
Expanding TAVI to Low and Intermediate Risk Patients
TAVI has become the standard treatment in patients at increased surgical risk and is increasingly being performed in patients at intermediate to low surgical risk. While non-inferiority has been demonstrated in intermediate risk patients, several challenges—particularly with regard to valve durabili...
Autores principales: | Voigtländer, Lisa, Seiffert, Moritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052659/ https://www.ncbi.nlm.nih.gov/pubmed/30050909 http://dx.doi.org/10.3389/fcvm.2018.00092 |
Ejemplares similares
-
TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve
por: Schneeberger, Yvonne, et al.
Publicado: (2022) -
Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device
por: Veulemans, Verena, et al.
Publicado: (2023) -
TAVI: Simplification Is the Ultimate Sophistication
por: Akodad, Mariama, et al.
Publicado: (2018) -
Editorial: TAVI and the Challenges Ahead
por: Spitzer, Ernest, et al.
Publicado: (2020) -
Valve-in-valve procedures for degenerated surgical and transcatheter aortic valve bioprostheses using a latest-generation self-expanding intra-annular transcatheter heart valve
por: Schaefer, Andreas, et al.
Publicado: (2023)